NARI 📈 Inari Medical - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US45332Y1091
NARI: Thrombectomy Devices, Catheters, Aspiration Systems
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California. Web URL: https://www.inarimedical.com
Additional Sources for NARI Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
NARI Stock Overview
Market Cap in USD | 3,322m |
Sector | Healthcare |
Industry | Medical Devices |
GiC Sub-Industry | Health Care Equipment |
IPO / Inception | 2020-05-22 |
NARI Stock Ratings
Growth 5y | -12.1% |
Fundamental | -25.0% |
Dividend | - |
Rel. Strength Industry | -331 |
Analysts | 4.2/5 |
Fair Price Momentum | 52.56 USD |
Fair Price DCF | 0.61 USD |
NARI Dividends
No Dividends PaidNARI Growth Ratios
Growth Correlation 3m | 93% |
Growth Correlation 12m | -19.2% |
Growth Correlation 5y | -64.9% |
CAGR 5y | 5.95% |
CAGR/Mean DD 5y | 0.15 |
Sharpe Ratio 12m | -0.16 |
Alpha | -47.32 |
Beta | 1.27 |
Volatility | 50.26% |
Current Volume | 2100.5k |
Average Volume 20d | 1170.3k |
What is the price of NARI stocks?
As of December 21, 2024, the stock is trading at USD 55.45 with a total of 2,100,473 shares traded.
Over the past week, the price has changed by -0.25%, over one month by +13.16%, over three months by +26.95% and over the past year by -11.87%.
As of December 21, 2024, the stock is trading at USD 55.45 with a total of 2,100,473 shares traded.
Over the past week, the price has changed by -0.25%, over one month by +13.16%, over three months by +26.95% and over the past year by -11.87%.
Is Inari Medical a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Inari Medical is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -24.96 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NARI as of December 2024 is 52.56. This means that NARI is currently overvalued and has a potential downside of -5.21%.
Neither. Based on ValueRay Fundamental Analyses, Inari Medical is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -24.96 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NARI as of December 2024 is 52.56. This means that NARI is currently overvalued and has a potential downside of -5.21%.
Is NARI a buy, sell or hold?
Inari Medical has received a consensus analysts rating of 4.20. Therefor, it is recommend to buy NARI.
Inari Medical has received a consensus analysts rating of 4.20. Therefor, it is recommend to buy NARI.
- Strong Buy: 8
- Buy: 2
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecast for NARI stock price target?
According to ValueRays Forecast Model, NARI Inari Medical will be worth about 58.9 in December 2025. The stock is currently trading at 55.45. This means that the stock has a potential upside of +6.22%.
According to ValueRays Forecast Model, NARI Inari Medical will be worth about 58.9 in December 2025. The stock is currently trading at 55.45. This means that the stock has a potential upside of +6.22%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 64.4 | 16.1% |
Analysts Target Price | 83.1 | 49.9% |
ValueRay Target Price | 58.9 | 6.2% |